Tandem Diabetes Care Inc (NASDAQ: TNDM) stock closed at $44.72 on 5/3/24 after a major increase of 22.3%. Moreover, exceptionally high trading volume at 311% of normal accompanied the advance. The stock has risen 25.8% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
TNDM is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Tandem Diabetes Care has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Tandem Diabetes Care has a very low Appreciation Score of 4 but a good Power Rating of 82, with the Negative Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment